Padagis US LLC 2023-12-13 Health serious FDA
Health · FDA · Recall #FDA-D-0139-2024
Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only,… Recall
Issued December 13, 2023 · Padagis US LLC
In December 2023, Padagis US LLC recalled the Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
What you should do
- 1 Stop using Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Padagis US LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Padagis US LLC
- Category
- Health
- Recall date
- December 13, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0139-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Padagis US LLC has 7 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.